Intercept Pharmaceuticals | ICPT - Ativos



Ativos Alterar Data
Acadia Pharmaceuticals USD 1.74B 137.67M 2026-06
Alnylam Pharmaceuticals USD 5.56B 429.22M 2026-06
Amarin USD 624.36M 21.4M 2026-06
Amgen USD 95.64B 3.14B 2026-06
Arrowhead Research USD 2.11B 156.25M 2026-06
AstraZeneca USD 115.83B 1.82B 2026-06
Biogen USD 32.09B 2.6B 2026-06
Bristol-Myers Squibb USD 87.63B 1.16B 2026-06
Eli Lilly USD 142.28B 25.71B 2026-06
Enanta Pharmaceuticals USD 329.5M 48.77M 2025-12
Galectin Therapeutics USD 27.65M 1.76M 2024-06
Gilead Sciences USD 49.36B 6.92B 2026-06
GlaxoSmithKline GBP 61.74B 1.13B 2026-06
Incyte USD 7.87B 533.53M 2026-06
Ionis Pharmaceuticals USD 2.99B 455.5M 2026-06
Moderna USD 10.96B 527M 2026-06
Neurocrine Biosciences USD 5.36B 452.9M 2026-06
Novartis USD 122.03B 3.5B 2026-06
PTC Therapeutics USD 3.25B 381.37M 2026-06
Regeneron Pharmaceuticals USD 41.73B 861.8M 2026-06
Sangamo BioSciences USD 97.56M 11.39M 2025-06
Sarepta Therapeutics USD 3.19B 9.58M 2026-06
Vertex Pharmaceuticals USD 27.42B 938.9M 2026-06